inspect molecule / korsuva
Korsuva
Difelikefalin Acetate o--o \/ /\ o--o
Difelikefalin Acetate is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyDifelikefalin Acetate
administration routeIntravenous
price comparison status2 snapshots
safety signal rating54 / 100
Kappa Opioid Receptor Agonist [EPC]openFDA NDC seedopenFDA NDC50 ug/mL
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Kappa Opioid Receptor Agonist [EPC].
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 9247 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Falling3M: -2.2%12M: -7.4%
Jul 2025Jun 2026
Jan 2026$25.37
Feb 2026$25.14
Mar 2026$25.06
Apr 2026$24.83
May 2026$24.75
Jun 2026$24.51
01 / chemistryVifor (International), Inc.
Ingredient Breakdown
active moietyDifelikefalin Acetate
formulationIntravenous Kappa Opioid Receptor Agonist [EPC]
mechanism of action
Kappa Opioid Receptor Agonist [EPC]
available strengths
50 ug/mL
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
- Read the official label for route-specific directions, contraindications, and storage.
- Ask a clinician or pharmacist before substituting products across countries or formulations.
- Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same
Same Ingredient Sibling Records
No same-ingredient sibling appears in the current indexed records yet.